MARSHALL WACE, LLP

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in ALLO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,598,448

+$2,185,368 QoQ

Shares Held

5,095,408

+47.8% QoQ

Ownership

1.47%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#15

of 209 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. ALLO ranks #68 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,598,448	5,095,408	+47.8%	Shares	Other	2026-08-13
2026-03-31	$8,413,080	3,447,984	+1107.4%	Shares	Other	2026-05-15
2025-12-31	$391,218	285,561	+24.9%	Shares	Other	2026-02-13
2023-09-30	$724,795	228,642	+427.5%	Shares	Other	2023-11-14
2023-06-30	$215,429	43,346	-90.0%	Shares	Other	2023-08-14
2023-03-31	$2,148,998	435,020	+3354.5%	Shares	Other	2023-05-15
2022-09-30	$136,004	12,593	-98.7%	Shares	Other	2022-11-14
2021-12-31	$14,153,470	948,624	+107.8%	Shares	Other	2022-02-14
2021-06-30	$11,907,893	456,591	+245.9%	Shares	Sole	2021-08-13
2020-03-31	$2,566,196	132,006	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.